Cargando…
Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters
Curative therapies for chronic hepatitis B virus (HBV) infection remain a distant goal, and the persistence of stable covalently closed circular DNA (cccDNA) during HBV replication is a key barrier that is hard to break through using the drugs currently approved for HBV treatment. Due to the accurac...
Autores principales: | Yan, Kun, Feng, Jiangpeng, Liu, Xing, Wang, Hongyun, Li, Qiaohong, Li, Jiali, Xu, Tianmo, Sajid, Muhammad, Ullah, Hafiz, Zhou, Li, Zhou, Limin, Chen, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271097/ https://www.ncbi.nlm.nih.gov/pubmed/34254007 http://dx.doi.org/10.3389/fmicb.2021.665184 |
Ejemplares similares
-
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
por: Li, Hao, et al.
Publicado: (2018) -
Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
por: Feng, Yan, et al.
Publicado: (2016) -
Improvement of muscular atrophy by AAV–SaCas9-mediated myostatin gene editing in aged mice
por: Weng, Shaoting, et al.
Publicado: (2020) -
Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons
por: Chen, Yuxi, et al.
Publicado: (2020) -
Developing a highly efficient and wildly adaptive CRISPR‐SaCas9 toolset for plant genome editing
por: Qin, Ruiying, et al.
Publicado: (2019)